These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 692284)

  • 1. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Walters DE; Chapman CD; Howard SG
    J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 5. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
    Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
    Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum.
    Adachi YU; Aramaki Y; Satomoto M; Higuchi H; Watanabe K
    Neurochem Int; 2003 Jul; 43(2):113-9. PubMed ID: 12620279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
    See RE; Murray CE
    Neurosci Lett; 1992 Aug; 142(1):100-4. PubMed ID: 1383895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat.
    Westerink BH; Damsma G; De Vries JB; Koning H
    Eur J Pharmacol; 1987 Mar; 135(2):123-8. PubMed ID: 3582491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute choline administration in rat and mouse: no effect on dopamine metabolism in brain.
    Flentge F; Postema F; Medema HM; Van den Berg CJ
    Life Sci; 1981 Jul; 29(4):331-5. PubMed ID: 7278490
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 15. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Waldmeier PC; Maître L
    J Neurochem; 1976 Aug; 27(2):589-97. PubMed ID: 989496
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of certain dopaminergic drugs on the striatal concentration of dopamine metabolites, with special reference to 3-methoxytramine.
    Ponzio F; Achilli G; Perego C; Algeri S
    Neurosci Lett; 1981 Nov; 27(1):61-7. PubMed ID: 7329624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
    Shibuya M; Fariello R; Farley IJ; Price KS; Lloyd KG; Hornykiewicz O
    Exp Neurol; 1978 Feb; 58(3):486-99. PubMed ID: 620704
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.